Huawei has just unveiled the new Watch 3 Pro, an updated version of their Watch 3 Pro. The most notable new feature of the watch is its electrocardiogram (EKG), which will help users monitor their heart health. Huawei is waiting for the approval of the EKG feature in the European Union and the UK. The watch is currently available in China only.
- Canada Approves Apple Watch AFib History, a Feature of Wear OS 9.0
- Apple WatchOS 8.7 Released With Enhanced Features
ECG features in the Huawei Watch 3 Pro is still waiting for approval in the European Union and the United Kingdom. As Huawei does not launch any product in the USA, FDA Approval for ECG is unnecessary.
Apple Watch Series 7, Samsung Galaxy Watch 4, and Fitbit Sense are the top smartwatches with ECG features. These watches detect and alert Atrial Fibrillation(AFib) – an abnormal heart rhythm that can lead to stroke, blood clots, and other heart-related problems.
The new Watch 3 Pro is running on the Harmony OS 3.0, which features turn-by-turn navigation by Baidu Maps and AutoNavi Map, two of China’s most popular map applications. Huawei’s Watch 3 Pro has a 1.39-inch AMOLED display with 466 x 466 pixels resolution and a 48mm case. The watch’s price in China is CNY 2,999, which is about $440. There is no information currently available about the global launch of the Watch 3 Pro.
The Watch 3 Pro is water resistant to up to 5 ATMs and supports eSIM connectivity, allowing users to make phone calls and use data without a smartphone. Huawei claims the watch will have a battery life of 2-days and supports wireless charging.